Please login to the form below

Germany

This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca divests Seroquel rights to focus on key therapy areas

Second divestment to Germany-based Cheplapharm this year. AstraZeneca has sold the commercial rights to schizophrenia and bipolar disorder drugs Seroquel and Seroquel XR to Cheplapharm. .

Latest news

Diurnal files adrenal insufficiency drug Alkindi in US

Alkindi has already been approved in Europe and launched in its first markets – including Germany and the UK – and is specifically designed to allow easier dosing in paediatric patients compared to ... The drug made its debut in Germany in 2018,
UK is a leader in early clinical research but falls in later study stages, says ABPI

In 2017, the UK ranked fifth globally for phase 3 trials, behind Germany, Spain, the US and Canada.
Merck claims first-ever okay for Ebola vaccine, in Europe

MSD says it will now start producing licensed doses of Ervebo at a facility in Germany that should become available in the third quarter of 2020, and in the meantime will
NICE backs first cannabis-based drugs, both from GW Pharma

GW says it has been working with the relevant bodies in the UK, Germany, Spain, France and Italy to secure reimbursement ahead of the anticipated launch of Epidyolex in these countries.
Takeda’s dengue vaccine seems safe with no prior virus exposure

It’s also investing in production capacity for TAK-003, and this week opened a 130m plant in Germany that it says will help it meet global demand at launch.

More from news
Approximately 44 fully matching, plus 837 partially matching documents found.

Latest Intelligence

Building European biotech firms to rival those of the US

Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... For a number of reasons, such as taxes and red tape, the sector hasn’t really taken off there as much as it could have until
European biotech: a new generation of leaders emerges

potential academic researchers across the continent, with a number of specialist venture capital firms and incubators helping to build success stories in the UK, France, Germany, Belgium and Denmark across a ... Morphosys. One of Europe’s star
A new EU in the making, what lies ahead for pharma?

The HTA file is in a difficult situation at the moment with Germany and France blocking it. ... For smaller companies however, the stakes are higher. If France, Germany and a few other countries want to support innovation and faster market uptake up to
Is anybody listening?

Similarly, authorities in Germany, China, Russia and Australia – as well as the EU in general – are all taking measures to clamp down on companies that aren’t doing enough to fulfil
Bluebird: on a mission to ‘recode’ the DNA of healthcare

Bluebird is focusing on Germany, Italy, France and the UK as its initial launch markets, as 90% of Europe’s beta thalassemia patients live in these four countries. ... He said conversations with Germany’s sick funds have been constructive so far, not

More from intelligence
Approximately 9 fully matching, plus 123 partially matching documents found.

Latest appointments

McCann Health Germany strengthens leadership team

Healthcare communications network McCann Health has made two key appointments to the leadership team of McCann Health Germany. . ... Guido Körfer (pictured above) has been appointed as president of McCann Health Germany.
Richard Paulson joins Ipsen as CEO for North America

During a 10-year career at Amgen, Paulson held a number positions at the company, including general manager of Germany and general manager of central and eastern Europe.
Dave Lemus joins Proteros as an executive board member

He joins the German biotech’s board from Medigene. Proteros, a private biotech based in Germany, has appointed Dave Lemus as an executive board member, chief operating officer and chief financial
MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team

She joins the Duesseldorf, Germany-based firm from MorphoSys, where she headed the corporate communications and investor relations department as senior vice president; a role that saw her took responsibility for
Paolo Carli appointed as head of MEA at Merck

He will be responsible for leading commercial operations. Germany's Merck has appointed Paolo Carli as its new head of healthcare business, taking the helm of its commercial operations for the ... Carli joined Merck in 2009 as a member of the mergers and

More from appointments
Approximately 2 fully matching, plus 74 partially matching documents found.

Latest from PMHub

Research Partnership opens new office in Lyon, France

She will have a remit to grow and expand the Lyon office as well as to service existing clients based in France, Switzerland and Germany.
OPEN Health announces the integration of Pharmerit International into the group

In terms of scale, the integration means OPEN Health will now consist of 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China.
Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports

The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients.
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.

Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation. ... Tombrink has been leading small and large teams in and outside of matrix organizations and will function as the country head of Cello Health Insight in
Report: Living with RA (EU, Japan and Canada) 2019 reports

Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK) and 55 patients in